Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ion Channel Gating | 21 | 2021 | 338 | 3.120 |
Why?
|
| Potassium Channels, Voltage-Gated | 14 | 2024 | 127 | 2.700 |
Why?
|
| KCNQ1 Potassium Channel | 9 | 2024 | 17 | 2.020 |
Why?
|
| Potassium | 7 | 2020 | 271 | 1.600 |
Why?
|
| Membrane Potentials | 12 | 2021 | 442 | 1.480 |
Why?
|
| Potassium Channel Blockers | 7 | 2023 | 67 | 1.450 |
Why?
|
| Potassium Channels | 4 | 2023 | 359 | 1.220 |
Why?
|
| Cricetulus | 7 | 2024 | 132 | 1.170 |
Why?
|
| Shab Potassium Channels | 8 | 2020 | 29 | 1.160 |
Why?
|
| Shaker Superfamily of Potassium Channels | 6 | 2016 | 51 | 1.030 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2022 | 140 | 0.930 |
Why?
|
| Probucol | 1 | 2024 | 2 | 0.880 |
Why?
|
| Myocytes, Cardiac | 3 | 2022 | 323 | 0.760 |
Why?
|
| Giant Cells | 1 | 2021 | 19 | 0.720 |
Why?
|
| Shaw Potassium Channels | 3 | 2016 | 8 | 0.700 |
Why?
|
| 4-Aminopyridine | 3 | 2015 | 37 | 0.620 |
Why?
|
| Long QT Syndrome | 2 | 2023 | 41 | 0.490 |
Why?
|
| Oocytes | 2 | 2020 | 227 | 0.480 |
Why?
|
| CHO Cells | 6 | 2024 | 196 | 0.470 |
Why?
|
| Antibodies | 2 | 2020 | 356 | 0.460 |
Why?
|
| Protein Subunits | 5 | 2015 | 126 | 0.460 |
Why?
|
| Kinetics | 12 | 2015 | 1561 | 0.460 |
Why?
|
| Ciguatoxins | 4 | 2016 | 4 | 0.420 |
Why?
|
| Action Potentials | 3 | 2022 | 629 | 0.410 |
Why?
|
| Patch-Clamp Techniques | 7 | 2016 | 402 | 0.410 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2012 | 25 | 0.380 |
Why?
|
| Animals | 26 | 2024 | 28901 | 0.370 |
Why?
|
| Mutation | 9 | 2018 | 4374 | 0.360 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2021 | 91 | 0.350 |
Why?
|
| Models, Molecular | 7 | 2021 | 1376 | 0.350 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2024 | 233 | 0.340 |
Why?
|
| Kv1.5 Potassium Channel | 2 | 2008 | 12 | 0.340 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2021 | 124 | 0.330 |
Why?
|
| Protein Conformation | 6 | 2018 | 935 | 0.320 |
Why?
|
| HEK293 Cells | 6 | 2021 | 706 | 0.310 |
Why?
|
| Genes, Dominant | 1 | 2009 | 115 | 0.310 |
Why?
|
| Biophysics | 1 | 2009 | 157 | 0.300 |
Why?
|
| Energy Transfer | 1 | 2008 | 27 | 0.290 |
Why?
|
| Protein Structure, Tertiary | 6 | 2014 | 750 | 0.280 |
Why?
|
| Models, Biological | 4 | 2011 | 1810 | 0.270 |
Why?
|
| Xenopus | 4 | 2020 | 130 | 0.270 |
Why?
|
| Cell Line | 8 | 2020 | 2536 | 0.260 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 3 | 2015 | 27 | 0.260 |
Why?
|
| Amino Acid Sequence | 8 | 2016 | 2090 | 0.260 |
Why?
|
| Cricetinae | 5 | 2023 | 542 | 0.250 |
Why?
|
| Structure-Activity Relationship | 6 | 2023 | 436 | 0.240 |
Why?
|
| Mutation, Missense | 2 | 2021 | 302 | 0.240 |
Why?
|
| Proline | 2 | 2015 | 56 | 0.230 |
Why?
|
| Culture Media, Serum-Free | 1 | 2024 | 22 | 0.220 |
Why?
|
| Humans | 28 | 2023 | 95992 | 0.210 |
Why?
|
| Cell Culture Techniques | 1 | 2024 | 197 | 0.200 |
Why?
|
| Thiophenes | 1 | 2023 | 45 | 0.200 |
Why?
|
| Alanine | 2 | 2018 | 85 | 0.190 |
Why?
|
| beta-Alanine | 1 | 2021 | 6 | 0.180 |
Why?
|
| Biotransformation | 1 | 2021 | 49 | 0.180 |
Why?
|
| Microsomes, Liver | 1 | 2021 | 49 | 0.180 |
Why?
|
| Desmoglein 2 | 1 | 2021 | 1 | 0.180 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 2 | 2012 | 11 | 0.180 |
Why?
|
| Andersen Syndrome | 1 | 2021 | 1 | 0.180 |
Why?
|
| Organogenesis | 1 | 2021 | 51 | 0.170 |
Why?
|
| Brugada Syndrome | 1 | 2021 | 15 | 0.170 |
Why?
|
| Larva | 1 | 2021 | 135 | 0.170 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2021 | 68 | 0.170 |
Why?
|
| Embryonic Development | 1 | 2021 | 86 | 0.170 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 50 | 0.170 |
Why?
|
| Gap Junctions | 1 | 2021 | 147 | 0.170 |
Why?
|
| Crystallography, X-Ray | 2 | 2018 | 527 | 0.170 |
Why?
|
| Molecular Sequence Data | 6 | 2014 | 3040 | 0.170 |
Why?
|
| Anticonvulsants | 1 | 2021 | 133 | 0.160 |
Why?
|
| Embryo, Nonmammalian | 1 | 2021 | 203 | 0.160 |
Why?
|
| Protein Multimerization | 3 | 2021 | 196 | 0.160 |
Why?
|
| Models, Cardiovascular | 1 | 2021 | 111 | 0.160 |
Why?
|
| Interleukin-6 | 1 | 2021 | 281 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 164 | 0.160 |
Why?
|
| Electrophysiology | 4 | 2011 | 408 | 0.160 |
Why?
|
| Binding Sites | 6 | 2016 | 1167 | 0.150 |
Why?
|
| Mice | 9 | 2021 | 12525 | 0.150 |
Why?
|
| Amino Acid Motifs | 3 | 2015 | 123 | 0.150 |
Why?
|
| NF-kappa B | 1 | 2021 | 469 | 0.140 |
Why?
|
| Cell Proliferation | 1 | 2024 | 1753 | 0.140 |
Why?
|
| Threonine | 1 | 2018 | 34 | 0.140 |
Why?
|
| Immunosuppressive Agents | 1 | 2023 | 997 | 0.140 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2008 | 282 | 0.140 |
Why?
|
| Allosteric Regulation | 1 | 2018 | 69 | 0.140 |
Why?
|
| Amino Acid Substitution | 3 | 2008 | 336 | 0.130 |
Why?
|
| 1-Butanol | 1 | 2016 | 3 | 0.130 |
Why?
|
| Camelus | 1 | 2016 | 6 | 0.120 |
Why?
|
| Microscopy, Confocal | 2 | 2009 | 286 | 0.120 |
Why?
|
| Alcohols | 1 | 2015 | 15 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 2 | 2015 | 516 | 0.120 |
Why?
|
| Immunization | 1 | 2016 | 165 | 0.120 |
Why?
|
| Antibody Formation | 1 | 2016 | 181 | 0.120 |
Why?
|
| Time Factors | 1 | 2024 | 5593 | 0.120 |
Why?
|
| Markov Chains | 1 | 2015 | 137 | 0.110 |
Why?
|
| Neurons | 2 | 2015 | 1654 | 0.110 |
Why?
|
| Transfection | 3 | 2015 | 908 | 0.100 |
Why?
|
| Mutagenesis | 2 | 2010 | 202 | 0.100 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2012 | 52 | 0.090 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 922 | 0.090 |
Why?
|
| Genes, Reporter | 1 | 2012 | 281 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 299 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2009 | 422 | 0.080 |
Why?
|
| Protein Structure, Secondary | 2 | 2008 | 342 | 0.080 |
Why?
|
| Recombinant Proteins | 2 | 2020 | 1006 | 0.080 |
Why?
|
| Electric Conductivity | 1 | 2010 | 147 | 0.080 |
Why?
|
| Protein Binding | 3 | 2015 | 1560 | 0.080 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 308 | 0.080 |
Why?
|
| Marine Toxins | 1 | 2009 | 7 | 0.080 |
Why?
|
| Molecular Biology | 1 | 2009 | 90 | 0.070 |
Why?
|
| Kidney | 2 | 2011 | 1135 | 0.070 |
Why?
|
| COS Cells | 3 | 2012 | 168 | 0.060 |
Why?
|
| Electromagnetic Fields | 1 | 2006 | 28 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 1533 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 1966 | 0.060 |
Why?
|
| Protein Folding | 1 | 2008 | 295 | 0.060 |
Why?
|
| Fibroblasts | 2 | 2020 | 776 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2008 | 1158 | 0.050 |
Why?
|
| Glycine | 1 | 2003 | 96 | 0.050 |
Why?
|
| Jervell-Lange Nielsen Syndrome | 1 | 2023 | 1 | 0.050 |
Why?
|
| Belgium | 1 | 2023 | 4 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 145 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 314 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 2059 | 0.050 |
Why?
|
| Estrenes | 1 | 2021 | 8 | 0.050 |
Why?
|
| Pyrrolidinones | 1 | 2021 | 16 | 0.050 |
Why?
|
| Teratogens | 1 | 2021 | 13 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 564 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2022 | 53 | 0.040 |
Why?
|
| Peptides, Cyclic | 1 | 2021 | 44 | 0.040 |
Why?
|
| Protein Structure, Quaternary | 1 | 2021 | 103 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 261 | 0.040 |
Why?
|
| Rabbits | 1 | 2021 | 639 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2021 | 522 | 0.040 |
Why?
|
| Photobleaching | 1 | 2020 | 8 | 0.040 |
Why?
|
| Xenopus laevis | 1 | 2020 | 143 | 0.040 |
Why?
|
| Alleles | 1 | 2023 | 1157 | 0.040 |
Why?
|
| Phenotype | 2 | 2021 | 2575 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2020 | 159 | 0.040 |
Why?
|
| Zebrafish | 1 | 2021 | 342 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 1267 | 0.040 |
Why?
|
| ERG1 Potassium Channel | 2 | 2010 | 15 | 0.040 |
Why?
|
| Heart Rate | 1 | 2021 | 533 | 0.040 |
Why?
|
| Male | 2 | 2021 | 45792 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2003 | 891 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 1309 | 0.030 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2016 | 10 | 0.030 |
Why?
|
| Hexanols | 1 | 2015 | 1 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 4155 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2022 | 1662 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2011 | 2928 | 0.030 |
Why?
|
| Permeability | 1 | 2013 | 144 | 0.020 |
Why?
|
| Electricity | 1 | 2012 | 26 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 2474 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2012 | 156 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2021 | 3581 | 0.020 |
Why?
|
| Polylysine | 1 | 2010 | 34 | 0.020 |
Why?
|
| Porosity | 1 | 2010 | 65 | 0.020 |
Why?
|
| Protein Stability | 1 | 2010 | 106 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 897 | 0.020 |
Why?
|
| Magnesium | 1 | 2010 | 178 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2010 | 368 | 0.020 |
Why?
|
| Child | 1 | 2021 | 7621 | 0.020 |
Why?
|
| Lysine | 1 | 2011 | 190 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 139 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2009 | 101 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 326 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2009 | 215 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2010 | 477 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2010 | 687 | 0.020 |
Why?
|
| Static Electricity | 1 | 2006 | 97 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 28299 | 0.010 |
Why?
|
| Female | 1 | 2021 | 49980 | 0.010 |
Why?
|